Barish, Charles
Dorn, Spencer
Fogel, Ronald P.
Patel, Reema
Rosenberg, Jonathan
Funding for this research was provided by:
Salix Pharmaceuticals, Inc.
Article History
Received: 14 January 2020
Accepted: 28 February 2020
First Online: 17 March 2020
Compliance with Ethical Standards
:
: Charles Barish: nothing to disclose. Spencer Dorn: consultant/advisory board member to Synergy Pharmaceuticals regarding Plecanatide. Ronald P. Fogel: nothing to disclose. Reema Patel: Bausch Health Employee. Jonathan Rosenberg: Speakers Bureaus for Allergan, Salix, Takeda.